News & Updates
Filter by Specialty:
Atrophic gastritis, PPI use amplify EC risk in immunocompetent patients
In immunocompetent patients admitted at a community hospital, comorbidities such as advanced gastric cancer and atrophic gastritis (AG), as well as treatment with proton pump inhibitors (PPI), seem to aggravate the risk of developing oesophageal candidiasis (EC), a recent study has found.
Atrophic gastritis, PPI use amplify EC risk in immunocompetent patients
26 Oct 2021Negative upper endoscopy findings in GERD signal lower upper gastrointestinal cancer risk
Negative upper endoscopy findings in patients with gastroesophageal reflux disease (GERD) indicate lower risk of developing upper gastrointestinal cancer, a new study has found.
Negative upper endoscopy findings in GERD signal lower upper gastrointestinal cancer risk
21 Oct 2021NLR, PLR improve early detection of second primary cancer after gastric cancer
Combining the neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios with existing diagnostic methods helps improve early detection of second primary cancers (SPC) after initial gastric cancer (GC), a recent study has found.
NLR, PLR improve early detection of second primary cancer after gastric cancer
20 Oct 2021Fatty pancreas carries increased risk of diabetes mellitus
Individuals with fatty pancreas appear to be at heightened risk of developing subsequent diabetes mellitus, but not hypertension or dyslipidaemia, as suggested in a study.
Fatty pancreas carries increased risk of diabetes mellitus
14 Oct 2021Fructose from fruit juice, SSBs tied to higher liver fat content
The consumption of fructose from fruit juice and sugar sweetened beverages (SSBs), but not from fruit, is associated with higher intrahepatic lipid (IHL) content, according to data from a cross-sectional study presented at EASD 2021.